Cargando…

Addressing Different Needs: The Challenges Faced by India as the Largest Vaccine Manufacturer While Conducting the World’s Biggest COVID-19 Vaccination Campaign

The COVID-19 pandemic has highlighted some of the challenges that countries face when balancing domestic and global necessities, for example with regard to vaccine needs, production and distribution. As India hosts one of the world’s largest vaccine manufacturing industries and has one of the most e...

Descripción completa

Detalles Bibliográficos
Autores principales: Koller, Cinja Nadana, Schwerzmann, Cléo Josephine, Lang, Alexia Suzanne Aimée, Alexiou, Eleni, Krishnakumar, Jaya
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9620944/
https://www.ncbi.nlm.nih.gov/pubmed/36417236
http://dx.doi.org/10.3390/epidemiologia2030032
_version_ 1784821430825779200
author Koller, Cinja Nadana
Schwerzmann, Cléo Josephine
Lang, Alexia Suzanne Aimée
Alexiou, Eleni
Krishnakumar, Jaya
author_facet Koller, Cinja Nadana
Schwerzmann, Cléo Josephine
Lang, Alexia Suzanne Aimée
Alexiou, Eleni
Krishnakumar, Jaya
author_sort Koller, Cinja Nadana
collection PubMed
description The COVID-19 pandemic has highlighted some of the challenges that countries face when balancing domestic and global necessities, for example with regard to vaccine needs, production and distribution. As India hosts one of the world’s largest vaccine manufacturing industries and has one of the most extensive vaccination strategies, the country is particularly exposed to these challenges. This has become all the more obvious as the country experienced a second pandemic wave in the first half of 2021, which has led to a total ban on exports of COVID-19 vaccines. An analysis of the national vaccination strategy and the domestic vaccine industry through review of peer-reviewed literature, grey literature, and news reports showed the fragile balance between domestic and international needs. A numerical comparison of India’s domestic COVID-19 vaccine needs, export agreements, and production capacities was conducted. It was found that at current production rates as of April 2021, meeting all of the needs and complying with all of the agreements would be impossible. Scale-ups in production, as promised by the industry, however, will enable the achievement of all targets in the long term.
format Online
Article
Text
id pubmed-9620944
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-96209442022-11-18 Addressing Different Needs: The Challenges Faced by India as the Largest Vaccine Manufacturer While Conducting the World’s Biggest COVID-19 Vaccination Campaign Koller, Cinja Nadana Schwerzmann, Cléo Josephine Lang, Alexia Suzanne Aimée Alexiou, Eleni Krishnakumar, Jaya Epidemiologia (Basel) Case Report The COVID-19 pandemic has highlighted some of the challenges that countries face when balancing domestic and global necessities, for example with regard to vaccine needs, production and distribution. As India hosts one of the world’s largest vaccine manufacturing industries and has one of the most extensive vaccination strategies, the country is particularly exposed to these challenges. This has become all the more obvious as the country experienced a second pandemic wave in the first half of 2021, which has led to a total ban on exports of COVID-19 vaccines. An analysis of the national vaccination strategy and the domestic vaccine industry through review of peer-reviewed literature, grey literature, and news reports showed the fragile balance between domestic and international needs. A numerical comparison of India’s domestic COVID-19 vaccine needs, export agreements, and production capacities was conducted. It was found that at current production rates as of April 2021, meeting all of the needs and complying with all of the agreements would be impossible. Scale-ups in production, as promised by the industry, however, will enable the achievement of all targets in the long term. MDPI 2021-09-17 /pmc/articles/PMC9620944/ /pubmed/36417236 http://dx.doi.org/10.3390/epidemiologia2030032 Text en © 2021 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Case Report
Koller, Cinja Nadana
Schwerzmann, Cléo Josephine
Lang, Alexia Suzanne Aimée
Alexiou, Eleni
Krishnakumar, Jaya
Addressing Different Needs: The Challenges Faced by India as the Largest Vaccine Manufacturer While Conducting the World’s Biggest COVID-19 Vaccination Campaign
title Addressing Different Needs: The Challenges Faced by India as the Largest Vaccine Manufacturer While Conducting the World’s Biggest COVID-19 Vaccination Campaign
title_full Addressing Different Needs: The Challenges Faced by India as the Largest Vaccine Manufacturer While Conducting the World’s Biggest COVID-19 Vaccination Campaign
title_fullStr Addressing Different Needs: The Challenges Faced by India as the Largest Vaccine Manufacturer While Conducting the World’s Biggest COVID-19 Vaccination Campaign
title_full_unstemmed Addressing Different Needs: The Challenges Faced by India as the Largest Vaccine Manufacturer While Conducting the World’s Biggest COVID-19 Vaccination Campaign
title_short Addressing Different Needs: The Challenges Faced by India as the Largest Vaccine Manufacturer While Conducting the World’s Biggest COVID-19 Vaccination Campaign
title_sort addressing different needs: the challenges faced by india as the largest vaccine manufacturer while conducting the world’s biggest covid-19 vaccination campaign
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9620944/
https://www.ncbi.nlm.nih.gov/pubmed/36417236
http://dx.doi.org/10.3390/epidemiologia2030032
work_keys_str_mv AT kollercinjanadana addressingdifferentneedsthechallengesfacedbyindiaasthelargestvaccinemanufacturerwhileconductingtheworldsbiggestcovid19vaccinationcampaign
AT schwerzmanncleojosephine addressingdifferentneedsthechallengesfacedbyindiaasthelargestvaccinemanufacturerwhileconductingtheworldsbiggestcovid19vaccinationcampaign
AT langalexiasuzanneaimee addressingdifferentneedsthechallengesfacedbyindiaasthelargestvaccinemanufacturerwhileconductingtheworldsbiggestcovid19vaccinationcampaign
AT alexioueleni addressingdifferentneedsthechallengesfacedbyindiaasthelargestvaccinemanufacturerwhileconductingtheworldsbiggestcovid19vaccinationcampaign
AT krishnakumarjaya addressingdifferentneedsthechallengesfacedbyindiaasthelargestvaccinemanufacturerwhileconductingtheworldsbiggestcovid19vaccinationcampaign